Abstract
While widely used in research, the 1991 Rome criteria for the gastroduodenal disorders, especially symptom subgroups in dyspepsia, remain contentious. After a comprehensive literature search, a consensus-based approach was applied, supplemented by input from international experts who reviewed the report. Three functional gastroduodenal disorders are defined. Functional dyspepsia is persistent or recurrent pain or discomfort centered in the upper abdomen; evidence of organic disease likely to explain the symptoms is absent, including at upper endoscopy. Discomfort refers to a subjective, negative feeling that may be characterized by or associated with a number of non-painful symptoms including upper abdominal fullness, early satiety, bloating, or nausea. A dyspepsia subgroup classification is proposed for research purposes, based on the predominant (most bothersome) symptom: (a) ulcer-like dyspepsia when pain (from mild to severe) is the predominant symptom, and (b) dysmotility-like dyspepsia when discomfort (not pain) is the predominant symptom. This classification is supported by recent evidence suggesting that predominant symptoms, but not symptom clusters, identify subgroups with distinct underlying pathophysiological disturbances and responses to treatment. Aerophagia is an unusual complaint characterized by air swallowing that is objectively observed and troublesome repetitive belching. Functional vomiting refers to frequent episodes of recurrent vomiting that is not self-induced nor medication induced, and occurs in the absence of eating disorders, major psychiatric diseases, abnormalities in the gut or central nervous system, or metabolic diseases that can explain the symptom. The current classification requires careful validation but the criteria should be of value in future research. Keywords: dyspepsia; functional dyspepsia; aerophagia; psychogenic vomiting; Rome II
Full Text
The Full Text of this article is available as a PDF (87.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Agréus L., Talley N. Challenges in managing dyspepsia in general practice. BMJ. 1997 Nov 15;315(7118):1284–1288. doi: 10.1136/bmj.315.7118.1284. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Baume P., Tracey M., Dawson L. Efficacy of two minor tranquilizers in relieveing symptoms of functional gastrointestinal distress. Aust N Z J Med. 1975 Dec;5(6):503–506. doi: 10.1111/j.1445-5994.1975.tb03850.x. [DOI] [PubMed] [Google Scholar]
- Brzana R. J., Koch K. L. Gastroesophageal reflux disease presenting with intractable nausea. Ann Intern Med. 1997 May 1;126(9):704–707. doi: 10.7326/0003-4819-126-9-199705010-00005. [DOI] [PubMed] [Google Scholar]
- Bytzer P., Hansen J. M., Schaffalitzky de Muckadell O. B., Malchow-Møller A. Predicting endoscopic diagnosis in the dyspeptic patient. The value of predictive score models. Scand J Gastroenterol. 1997 Feb;32(2):118–125. doi: 10.3109/00365529709000181. [DOI] [PubMed] [Google Scholar]
- Chiba N., Bernard L., O'Brien B. J., Goeree R., Hunt R. H. A Canadian physician survey of dyspepsia management. Can J Gastroenterol. 1998 Jan-Feb;12(1):83–90. doi: 10.1155/1998/175926. [DOI] [PubMed] [Google Scholar]
- Farup P. G., Hovde O., Breder O. Are frequent short gastro-oesophageal reflux episodes the cause of symptoms in patients with non-ulcer dyspepsia responding to treatment with ranitidine? Scand J Gastroenterol. 1995 Sep;30(9):829–832. doi: 10.3109/00365529509101587. [DOI] [PubMed] [Google Scholar]
- Finney J. S., Kinnersley N., Hughes M., O'Bryan-Tear C. G., Lothian J. Meta-analysis of antisecretory and gastrokinetic compounds in functional dyspepsia. J Clin Gastroenterol. 1998 Jun;26(4):312–320. doi: 10.1097/00004836-199806000-00022. [DOI] [PubMed] [Google Scholar]
- Forbes G. M., Glaser M. E., Cullen D. J., Warren J. R., Christiansen K. J., Marshall B. J., Collins B. J. Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up. Lancet. 1994 Jan 29;343(8892):258–260. doi: 10.1016/s0140-6736(94)91111-8. [DOI] [PubMed] [Google Scholar]
- Friedman L. S. Helicobacter pylori and nonulcer dyspepsia. N Engl J Med. 1998 Dec 24;339(26):1928–1930. doi: 10.1056/NEJM199812243392611. [DOI] [PubMed] [Google Scholar]
- Hansen J. M., Bytzer P., Schaffalitzky de Muckadell O. B. Placebo-controlled trial of cisapride and nizatidine in unselected patients with functional dyspepsia. Am J Gastroenterol. 1998 Mar;93(3):368–374. doi: 10.1111/j.1572-0241.1998.00368.x. [DOI] [PubMed] [Google Scholar]
- Heading R. C. Definitions of dyspepsia. Scand J Gastroenterol Suppl. 1991;182:1–6. doi: 10.3109/00365529109109529. [DOI] [PubMed] [Google Scholar]
- Jian R., Ducrot F., Ruskone A., Chaussade S., Rambaud J. C., Modigliani R., Rain J. D., Bernier J. J. Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride. Dig Dis Sci. 1989 May;34(5):657–664. doi: 10.1007/BF01540334. [DOI] [PubMed] [Google Scholar]
- Kellow J. E., Cowan H., Shuter B., Riley J. W., Lunzer M. R., Eckstein R. P., Höschl R., Lam S. K. Efficacy of cisapride therapy in functional dyspepsia. Aliment Pharmacol Ther. 1995 Apr;9(2):153–160. doi: 10.1111/j.1365-2036.1995.tb00364.x. [DOI] [PubMed] [Google Scholar]
- Klauser A. G., Schindlbeck N. E., Müller-Lissner S. A. Symptoms in gastro-oesophageal reflux disease. Lancet. 1990 Jan 27;335(8683):205–208. doi: 10.1016/0140-6736(90)90287-f. [DOI] [PubMed] [Google Scholar]
- Klauser A. G., Voderholzer W. A., Knesewitsch P. A., Schindlbeck N. E., Müller-Lissner S. A. What is behind dyspepsia? Dig Dis Sci. 1993 Jan;38(1):147–154. doi: 10.1007/BF01296788. [DOI] [PubMed] [Google Scholar]
- Koch K. L. Dyspepsia of unknown origin: pathophysiology, diagnosis, and treatment. Dig Dis. 1997 Nov-Dec;15(6):316–329. doi: 10.1159/000171608. [DOI] [PubMed] [Google Scholar]
- Malagelada J. R. The quest for a physiological answer to dyspepsia. Gastroenterology. 1998 Dec;115(6):1586–1588. doi: 10.1016/s0016-5085(98)70041-1. [DOI] [PubMed] [Google Scholar]
- Malcolm A., Thumshirn M. B., Camilleri M., Williams D. E. Rumination syndrome. Mayo Clin Proc. 1997 Jul;72(7):646–652. doi: 10.1016/S0025-6196(11)63571-4. [DOI] [PubMed] [Google Scholar]
- Malfertheiner P., Mégraud F., O'Morain C., Bell D., Bianchi Porro G., Deltenre M., Forman D., Gasbarrini G., Jaup B., Misiewicz J. J. Current European concepts in the management of Helicobacter pylori infection--the Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol. 1997 Jan;9(1):1–2. doi: 10.1097/00042737-199701000-00002. [DOI] [PubMed] [Google Scholar]
- Management of dyspepsia: report of a working party. Lancet. 1988 Mar 12;1(8585):576–579. [PubMed] [Google Scholar]
- McColl K. E., el-Nujumi A., Murray L., el-Omar E., Gillen D., Dickson A., Kelman A., Hilditch T. E. The Helicobacter pylori breath test: a surrogate marker for peptic ulcer disease in dyspeptic patients. Gut. 1997 Mar;40(3):302–306. doi: 10.1136/gut.40.3.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Small P. K., Loudon M. A., Waldron B., Smith D., Campbell F. C. Importance of reflux symptoms in functional dyspepsia. Gut. 1995 Feb;36(2):189–192. doi: 10.1136/gut.36.2.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sonnenberg A., Delcò F., El-Serag H. B. Empirical therapy versus diagnostic tests in gastroesophageal reflux disease: a medical decision analysis. Dig Dis Sci. 1998 May;43(5):1001–1008. doi: 10.1023/a:1018874516807. [DOI] [PubMed] [Google Scholar]
- Stanghellini V., Tosetti C., Paternico A., Barbara G., Morselli-Labate A. M., Monetti N., Marengo M., Corinaldesi R. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology. 1996 Apr;110(4):1036–1042. doi: 10.1053/gast.1996.v110.pm8612991. [DOI] [PubMed] [Google Scholar]
- Talley N. J., Boyce P., Jones M. Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population. Gut. 1998 May;42(5):690–695. doi: 10.1136/gut.42.5.690. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Talley N. J., Meineche-Schmidt V., Paré P., Duckworth M., Räisänen P., Pap A., Kordecki H., Schmid V. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther. 1998 Nov;12(11):1055–1065. doi: 10.1046/j.1365-2036.1998.00410.x. [DOI] [PubMed] [Google Scholar]
- Talley N. J. Review article: functional dyspepsia--should treatment be targeted on disturbed physiology? Aliment Pharmacol Ther. 1995 Apr;9(2):107–115. doi: 10.1111/j.1365-2036.1995.tb00359.x. [DOI] [PubMed] [Google Scholar]
- Talley N. J., Silverstein M. D., Agréus L., Nyrén O., Sonnenberg A., Holtmann G. AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology. 1998 Mar;114(3):582–595. doi: 10.1016/s0016-5085(98)70542-6. [DOI] [PubMed] [Google Scholar]
- Talley N. J., Zinsmeister A. R., Schleck C. D., Melton L. J., 3rd Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology. 1992 Apr;102(4 Pt 1):1259–1268. [PubMed] [Google Scholar]
- Veldhuyzen van Zanten S. J., Cleary C., Talley N. J., Peterson T. C., Nyrén O., Bradley L. A., Verlinden M., Tytgat G. N. Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol. 1996 Apr;91(4):660–673. [PubMed] [Google Scholar]
- Veldhuyzen van Zanten S. J., Talley N. J. Should antibiotic treatment of Helicobacter-positive patients with non-ulcer dyspepsia now be recommended? Eur J Gastroenterol Hepatol. 1998 May;10(5):367–370. doi: 10.1097/00042737-199805000-00002. [DOI] [PubMed] [Google Scholar]